Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe add-on to Atorvastatin in Hypercholesterolemia and CHD
NCT00651404Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ezetimibe in hypercholesterolemia, coronary heart disease (CHD), sponsored by Organon & Co.. Started Jan 2004; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemiacoronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00651404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651404.